BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27746401)

  • 1. Preclinical determination of the best functional position for transcatheter heart valves implanted in rapid deployment bioprostheses.
    Schäfer T; Doose C; Fujita B; Utzenrath M; Egron S; Schmitz C; Scholtz S; Kütting M; Hakim-Meibodi K; Börgermann J; Gummert J; Steinseifer U; Ensminger S
    EuroIntervention; 2017 Feb; 12(14):1706-1714. PubMed ID: 27746401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How Can We Help a Patient With a Small Failing Bioprosthesis?: An In Vitro Case Study.
    Midha PA; Raghav V; Condado JF; Arjunon S; Uceda DE; Lerakis S; Thourani VH; Babaliaros V; Yoganathan AP
    JACC Cardiovasc Interv; 2015 Dec; 8(15):2026-2033. PubMed ID: 26627992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoroscopic guide to an ideal implant position for Sapien XT and CoreValve during a valve-in-valve procedure.
    Bapat VN; Attia RQ; Condemi F; Visagan R; Guthrie M; Sunni S; Thomas M
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1186-94. PubMed ID: 24139931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valve-in-Valve Procedures in Failing Biological Xenografts Using a Novel Balloon-Expandable Device: Experience in Aortic, Mitral, and Tricuspid Positions.
    Schaefer A; Conradi L; Seiffert M; Lubos E; Blankenberg S; Reichenspurner H; Schaefer U; Treede H
    Thorac Cardiovasc Surg; 2016 Aug; 64(5):366-73. PubMed ID: 26277078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valve Type, Size, and Deployment Location Affect Hemodynamics in an In Vitro Valve-in-Valve Model.
    Midha PA; Raghav V; Condado JF; Okafor IU; Lerakis S; Thourani VH; Babaliaros V; Yoganathan AP
    JACC Cardiovasc Interv; 2016 Aug; 9(15):1618-28. PubMed ID: 27491613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A bench test study of bioprosthetic valve fracture performed before versus after transcatheter valve-in-valve intervention.
    Sathananthan J; Fraser R; Hatoum H; Barlow AM; Stanová V; Allen KB; Chhatriwalla AK; Rieu R; Pibarot P; Dasi LP; Søndergaard L; Wood DA; Webb JG
    EuroIntervention; 2020 Mar; 15(16):1409-1416. PubMed ID: 31854302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of different valve-in-valve positions on the hydrodynamic performance of the newest-generation self-expanding transcatheter heart valve.
    Sadat N; Bruhn D; Scharfschwerdt M; Schaller T; Aboud A; Saisho H; Eitel I; Ensminger S; Fujita B
    Eur J Cardiothorac Surg; 2022 Oct; 62(5):. PubMed ID: 35333318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcatheter valve-in-valve implantation for failed balloon-expandable transcatheter aortic valves.
    Toggweiler S; Wood DA; Rodés-Cabau J; Kapadia S; Willson AB; Ye J; Cheung A; Leipsic J; Binder RK; Gurvitch R; Freeman M; Thompson CR; Svensson LG; Dumont E; Tuzcu EM; Webb JG
    JACC Cardiovasc Interv; 2012 May; 5(5):571-577. PubMed ID: 22625197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-in-human valve-in-valve implantation of a 20 mm balloon expandable transcatheter heart valve.
    Binder RK; Wood D; Webb JG; Cheung A
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):E929-31. PubMed ID: 22821872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of hydrodynamic testing to guide sizing of self-expanding transcatheter heart valves for valve-in-valve procedures.
    Sathananthan J; Hensey M; Fraser R; Landes U; Blanke P; Hatoum H; Dasi LP; Sedaghat A; Bapat VN; Leipsic J; Søndergaard L; Wood DA; Webb JG
    Catheter Cardiovasc Interv; 2020 Sep; 96(3):E332-E340. PubMed ID: 31647178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trans-catheter valve-in-valve implantation: in vitro hydrodynamic performance of the SAPIEN+cloth trans-catheter heart valve in the Carpentier-Edwards Perimount valves.
    Walther T; Dehdashtian MM; Khanna R; Young E; Goldbrunner PJ; Lee W
    Eur J Cardiothorac Surg; 2011 Nov; 40(5):1120-6. PubMed ID: 21466959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of high-pressure balloon aortic valvuloplasty on the hydrodynamic result after a transcatheter valve-in-valve procedure.
    Sadat N; Bruhn D; Scharfschwerdt M; Schaller T; Aboud A; Saisho H; Eitel I; Ensminger S; Fujita B
    Catheter Cardiovasc Interv; 2022 Nov; 100(5):841-849. PubMed ID: 36040748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valve-in-valve implantation with a 23-mm balloon-expandable transcatheter heart valve for the treatment of a 19-mm stentless bioprosthesis severe aortic regurgitation using a strategy of "extreme" underfilling.
    Chevalier F; Leipsic J; Généreux P
    Catheter Cardiovasc Interv; 2014 Sep; 84(3):503-8. PubMed ID: 24402706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Strategy of Underexpansion and Ad Hoc Post-Dilation of Balloon-Expandable Transcatheter Aortic Valves in Patients at Risk of Annular Injury: Favorable Mid-Term Outcomes.
    Tan JS; Leipsic J; Perlman G; Stub D; Dvir D; Hansson NC; Norgaard BL; Blanke P; Cheung A; Ye J; Thompson CR; Moss RR; Lauck S; Wood D; Webb J
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1727-32. PubMed ID: 26476612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of post-implant SAPIEN XT geometry and position on conduction disturbances, hemodynamic performance, and paravalvular regurgitation.
    Binder RK; Webb JG; Toggweiler S; Freeman M; Barbanti M; Willson AB; Alhassan D; Hague CJ; Wood DA; Leipsic J
    JACC Cardiovasc Interv; 2013 May; 6(5):462-8. PubMed ID: 23702010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Underexpansion and ad hoc post-dilation in selected patients undergoing balloon-expandable transcatheter aortic valve replacement.
    Barbanti M; Leipsic J; Binder R; Dvir D; Tan J; Freeman M; Norgaard B; Hansson N; Cheung A; Ye J; Yang TH; Maryniak K; Raju R; Thompson A; Blanke P; Lauck S; Wood D; Webb J
    J Am Coll Cardiol; 2014 Mar; 63(10):976-81. PubMed ID: 24211502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do rapid deployment aortic valves improve outcomes compared with surgical aortic valve replacement?
    Davies RA; Bandara TD; Perera NK; Orr Y
    Interact Cardiovasc Thorac Surg; 2016 Nov; 23(5):814-820. PubMed ID: 27371610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcatheter valve-in-valve implantation with the Edwards SAPIEN in patients with bioprosthetic heart valve failure: the Milan experience.
    Latib A; Ielasi A; Montorfano M; Maisano F; Chieffo A; Cioni M; Mussardo M; Bertoldi L; Shannon J; Sacco F; Covello RD; Figini F; Godino C; Grimaldi A; Spagnolo P; Alfieri O; Colombo A
    EuroIntervention; 2012 Mar; 7(11):1275-84. PubMed ID: 22278193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First in human implantation of the mechanical expanding Lotus® valve in degenerated surgical valves in mitral position.
    Schaefer U; Conradi L; Lubos E; Deuschl F; Schofer N; Seiffert M; Treede H; Schirmer J; Reichenspurner H; Blankenberg S
    Catheter Cardiovasc Interv; 2015 Dec; 86(7):1280-6. PubMed ID: 26389782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfemoral implantation of transcatheter heart valves after deterioration of mitral bioprosthesis or previous ring annuloplasty.
    Bouleti C; Fassa AA; Himbert D; Brochet E; Ducrocq G; Nejjari M; Ghodbane W; Depoix JP; Nataf P; Vahanian A
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):83-91. PubMed ID: 25616821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.